Ascendis Pharma A/S (NASDAQ:ASND)
| 95.07 Delayed Data As of 3:59pm ET |  -0.37 / -0.39%Today’s Change | 64.33 Today|||52-Week Range 134.53 | -22.16% Year-to-Date |
Latest ASND News | Press Releases
| Ascendis Pharma A/S (ASND) Soars 3.2%: Is Further Upside Left in the Stock? Sep 15 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 95.44 |
| Today’s open | 95.78 |
| Day’s range | 94.56 - 96.67 |
| Volume | 5,885 |
| Average volume (3 months) | 272,806 |
| Market cap | $5.9B |
Data as of 3:59pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | -32.06% |
| Earnings growth (this year) | +5.90% |
| Earnings growth (next 5 years) | +30.12% |
| Revenue growth (last year) | +485.01% |
| P/E ratio | NM |
| Price/Sales | 127.33 |
| Price/Book | 20.46 |
Financials
| Next reporting date | November 29, 2023 |
| EPS forecast (this quarter) | -$2.46 |
| Annual revenue (last year) | $53.8M |
| Annual profit (last year) | -$612.9M |
| Net profit margin | -1,139.63% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Hellerup, Capital Region |
Forecasts
